Format

Send to

Choose Destination
Cancer Res. 1993 Oct 1;53(19):4486-8.

Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors.

Author information

1
Ludwig Institute for Cancer Research, La Jolla, California 92093-0660.

Abstract

The familial association of breast cancer with other tumors such as rhabdomyosarcoma that show loss of heterozygosity (LOH) for chromosome 11p15 as well as limited analyses showing LOH for chromosome 11p in breast tumors suggests the presence of a pleiotropic tumor suppressor gene in this region. In order to test this idea, we analyzed DNA samples for 50 matched normal and tumor tissues from unselected breast cancer patients for LOH at loci throughout the chromosome 11p15.5 region. We found that 12.5% of informative cases showed LOH at HRAS1, 26.8% at TH, and 33.3% at both D11S860 and HBB, providing genetic support for this hypothesis. In contrast to previous observations which excluded the involvement of 11p15.5 regions distal to the HBB cluster, our results indicate that the subregion between TH and HBB is a critical region in breast cancer. This region is identical to that identified for the clinically associated tumor, rhabdomyosarcoma, and thus warrants intensive molecular analysis.

PMID:
8402619
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center